Related Experiment Videos
Nonpeptide antagonists for kinin receptors
M Altamura1, S Meini, L Quartara
1Menarini Ricerche S.p.A., Firenze, Italy. maltamura@menarini-ricerche.it
Regulatory Peptides
|May 11, 1999
Summary
Kinins, like bradykinin, mediate inflammation and pain. Novel nonpeptide antagonists targeting kinin B1 and B2 receptors show promise for treating inflammatory diseases and pain, offering new therapeutic avenues.
Area of Science:
- Pharmacology
- Medicinal Chemistry
Background:
- Kinins are peptide mediators of inflammation and pain.
- Bradykinin (BK) and kallidin (KD) are key mammalian kinins.
- Kinin actions are mediated by B1 and B2 receptors.
Purpose of the Study:
- To review the development of nonpeptide antagonists for kinin B1 and B2 receptors.
- To highlight compounds with potential analgesic and anti-inflammatory properties.
Main Methods:
- Review of published literature on kinin receptor antagonists.
- Analysis of chemical structures and pharmacological data of identified compounds.
Main Results:
- The first nonpeptide B2 receptor antagonist (WIN 64338) was reported in 1993.
- Quinoline and imidazo[1,2-a]pyridine derivatives show high affinity and selectivity for B2 receptors (e.g., FR 173657, FR 190997).
- A single nonpeptide B1 receptor ligand has been reported.
Conclusions:
- Nonpeptide kinin receptor antagonists offer potential therapeutic applications for inflammatory conditions and pain.
- Continued research in rational design and library screening may yield further novel ligands.